Advanced Search

Technical Analysis for LEGN - Legend Biotech Corporation

Grade Last Price % Change Price Change
F 27.35 -5.23% -1.51
LEGN closed down 5.23 percent on Friday, January 22, 2021, on 2.19 times normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical LEGN trend table...
Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -5.23%
Fell Below 50 DMA Bearish -5.23%
Multiple of Ten Bearish Other -5.23%
Slingshot Bullish Bullish Swing Setup -13.04%
Overbought Stochastic Strength -13.04%
Upper Bollinger Band Touch Strength -13.04%
MACD Bullish Centerline Cross Bullish -15.59%
Pocket Pivot Bullish Swing Setup -15.59%
Older End-of-Day Signals for LEGN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
2x Volume Pace about 14 hours ago
Down 5% about 15 hours ago
60 Minute Opening Range Breakdown about 17 hours ago
Down 3% about 17 hours ago
1.5x Volume Pace about 20 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
Legend Biotech Corporation develops cell therapy solutions for cancer patients. The company was founded in 2014 and is based in Cayman Islands. The company operates as a subsidiary of Genscript Biotech Corporation.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Cell Therapy Genscript Biotech Spotlight Innovation

Is LEGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Dec 21 Janssen, begins rolling submission of marketing application for BCMA Car-T therapy in multiple myeloma
Dec 21 Legend Biotech Announces Initiation of Rolling Submission of Biologics License Application to U.S. FDA Seeking Approval of BCMA CAR-T Therapy Cilta-cel for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Dec 15 Legend Biotech to Participate in the 39th Annual J.P. Morgan Healthcare Conference
Dec 14 Legend Biotech added to the NASDAQ Biotechnology Index
Dec 14 Legend Biotech Added to the NASDAQ Biotechnology Index
Dec 14 Legend Biotech on go with early-stage stage with CAR-T candidate in blood cancer
Dec 14 Legend Biotech Announces FDA Clearance of the IND for LB1901, an Investigational Autologous Anti-CD4 CAR-T Therapy for Relapsed or Refractory T-Cell Lymphoma
Dec 13 Is LEGN A Good Stock To Buy Now?
Dec 7 Legend Biotech sinks ~7% amid safety concerns over JNJ’s multiple myeloma candidate
Dec 5 Legend Biotech Announces Phase 1b/2 Study Data of Cilta-cel, an Investigational BCMA CAR-T, Showing Early, Deep, and Durable Responses in Heavily Pretreated Patients with Multiple Myeloma
See more LEGN news...

Indicators

Indicator Value
52 Week High 43.2399
52 Week Low 24.64
Average Volume 303,854
200-Day Moving Average 0.00
50-Day Moving Average 29.25
20-Day Moving Average 29.30
10-Day Moving Average 29.61
Average True Range 1.74
ADX 13.06
+DI 21.72
-DI 24.27
Chandelier Exit (Long, 3 ATRs ) 28.01
Chandelier Exit (Short, 3 ATRs ) 31.77
Upper Bollinger Band 31.67
Lower Bollinger Band 26.92
Percent B (%b) 0.09
BandWidth 16.22
MACD Line 0.01
MACD Signal Line 0.07
MACD Histogram -0.0635
Fundamentals Value
Market Cap 3.53 Billion
Num Shares 129 Million
EPS -0.32
Price-to-Earnings (P/E) Ratio -85.87
Price-to-Sales 74.80
Price-to-Book 12.14
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.98
Resistance 3 (R3) 30.23 29.62 29.54
Resistance 2 (R2) 29.62 28.95 29.49 29.39
Resistance 1 (R1) 28.48 28.54 28.18 28.23 29.25
Pivot Point 27.87 27.87 27.71 27.74 27.87
Support 1 (S1) 26.73 27.20 26.43 26.48 25.45
Support 2 (S2) 26.12 26.79 25.99 25.31
Support 3 (S3) 24.98 26.12 25.16
Support 4 (S4) 24.73